Event Participants
Executives
5 Abhishek Jain, Aparna Iyer, Hari Shetty, Saurabh Govil, Srini Pallia
Analysts
5 Abhishek Bhandari, Nitin Padmanabhan, Rajiv Berlia, Ravi Menon, Vibhor Singhal
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| IT Services Revenue (CC) | $2.61 billion | +0.9% YoY, -1.2% QoQ; within guided range; growth led by APMEA (+13.5% YoY) and Europe (+6% YoY), partly offset by Americas softness |
| Order Bookings | $3.4 billion | Includes 13 large deals totaling $1.6 billion; some deal decisions slipped into Q2 |
| IT Services Margin | 16.0% | -120 bps YoY; impacted by salary increases, large-deal ramp-ups and AI investments, partially offset by rupee depreciation and operational efficiencies |
| Net Income | ₹33.6 billion | +0.6% YoY |
| EPS | ₹3.2 | +0.6% YoY |
| Operating Cash Flow | 98% of net income | Healthy cash conversion for Q1 |
| Gross Cash & Investments | $4.3 billion | Accounting yield on India-held investments stable at 7.2% |
| Effective Tax Rate | 22.6% | vs 21.6% in Q1 FY26 |
| Interim Dividend | ₹2 per share | Total shareholder returns exceeded $3 billion over last 12 months |
| Organic Headcount | -2,500 QoQ | Excludes Mindsprint joiners; management noted attrition remains under control |
Geographic & Segment Commentary
- Americas 1: Flattish YoY, -2.3% QoQ; region remains soft with modest recovery signals in BFSI.
- Americas 2: Declined 7.3% YoY and 2.5% QoQ; weakest geography, no specific driver called out.
- Europe: Grew 6% YoY, -0.9% QoQ; strong traction in BFSI and technology & communications; healthy pipeline across UK and Nordics.
- APMEA: Grew 13.5% YoY and 4.4% QoQ; strongest region, driven by BFSI and consumer sectors.
- BFSI: Grew 2.6% YoY, -1.2% QoQ; Europe and APMEA grew YoY on large-deal ramp-ups; Americas momentum building; client insourcing impact is behind; cost optimization and vendor consolidation remain key drivers, with savings being reinvested into AI.
- Consumer: Grew 1.9% YoY and 0.7% QoQ; some good wins in Americas.
- Technology & Communication: Grew 10.8% YoY and 0.2% QoQ; strongest sector, led by Americas momentum expected to continue.
- Health: Declined 3.0% YoY and 2.6% QoQ; US payer/provider ecosystem under structural pressure; budgets reallocated toward AI and regulatory compliance.
- Energy, Manufacturing & Resources (EMR): Declined 8.9% YoY and 3.6% QoQ; softness in Europe and APMEA, though new European deal wins expected to ramp into delivery.
Company-Specific & Strategic Commentary
- Mindsprint Acquisition: Closed during Q1 and moved from integration planning to execution; deepening Olam Group relationship and seeing opportunities in the food and agriculture sector.
- AI-Native Business & Platforms Unit: Launched last quarter, now moved decisively from strategy to execution; building multiple AI-powered industry platforms, hiring specialized AI-native leadership, and forging AI ecosystem partnerships.
- Anthropic Partnership: Launched Applied AI Center of Excellence for Claude models to help clients adopt frontier AI with enterprise-grade governance and controls.
- AI Credentials: Capco won the AI Governance and Risk Excellence Award at the OpenAI Partner Summit; Wipro's UK AI Lab won the OpenAI Codex Hackathon for an AI-powered banking solution.
- Wipro Ventures: $500 million fund now specifically targeting AI, data and security startups to enhance the Wipro Intelligence platform.
- Wipro Innovation Network: Launched 10 innovation networks for client co-innovation, gaining traction.
- WINGS Platform: AI-led delivery platform within Wipro Intelligence gaining traction; client examples include finance/procurement automation for an industrial manufacturer, pharma-covigilance transformation for a life sciences client, and application management for a European specialty chemicals company.
- AI Client Outcomes: Multi-agent AI deployment for a healthcare client reduced provider enrollment processing times up to 70% and automated up to 90% of manual effort; physical AI robotics strategy defined for a global energy leader.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Q2 FY27 IT Services Revenue | $2.574–$2.627 billion | Sequential -1.5% to +0.5% in constant currency; reflects soft demand environment and geopolitical uncertainty; includes full-quarter Mindsprint revenue contribution |
| IT Services Margin | Return to 17%–17.5% band | Committed to the band but no timeline given amid revenue volatility; will continue investing in AI-native business while pursuing productivity, G&A and pyramid restructuring levers |
| Shareholder Returns | >$3 billion returned over last 12 months | Includes the ₹2 interim dividend declared for Q1; consistent with capital-return policy |
Risks & Constraints
| Risk | Context |
|---|---|
| Macro & geopolitical uncertainty | Client decision cycles are longer and spending is more measured; Q2 guidance (-1.5% to +0.5% QoQ) embeds continued softness, with management declining to forecast beyond one quarter |
| Discretionary spend weakness | Delayed decision-making and slower ramp-up of large deals, particularly in BFSI, pressured Q1 revenue; recovery depends on clients reinvesting cost savings into AI transformation |
| US Healthcare structural pressure | Sustained cost and demographic pressures in the US payer/provider ecosystem have kept budgets flattish or negative; management gave no specific recovery timeline for the Health sector |
| Competitive pressure in traditional deals | Cost optimization and vendor consolidation deals remain intensely competitive, with forward productivity expectations compressing margins; management sees better margins in net-new Reimagine AI work |
| AI-driven compression of legacy IT/BPO | Clients are aggressively shifting budgets from traditional IT and BPO toward AI and agentic automation, requiring Wipro to reposition offerings and manage total cost of ownership (including token costs) |
| EMR sector softness | Down 8.9% YoY with weakness in Europe and APMEA; management expects recently won European deals to ramp but no timeline was provided |
Q&A Highlights
Headcount & Mindsprint Contribution
- Question: Why add headcount when Q2 guidance implies a sequential decline? (Ravi Menon, Axis Capital)
- Answer: Reported headcount includes Mindsprint joiners; excluding Mindsprint, headcount declined by ~2,500 QoQ. Q2 guidance includes full Mindsprint revenues. (Aparna Iyer, Srini Pallia)
BFSI Decline, Insourcing & Recovery
- Question: Is the BFSI decline client-specific, and does it persist into Q2? (Ravi Menon, Axis Capital)
- Answer: BFSI grew 2.6% YoY, with Europe and APMEA growing YoY on large-deal ramp-ups. The QoQ decline reflects slower large-deal scaling and slower discretionary spend, not client insourcing, which is now behind. Cost optimization and vendor consolidation remain client priorities, but savings are being reinvested into AI capabilities, which should revive transformation spend. (Srini Pallia, Aparna Iyer)
Margin Recovery Path
- Question: Will margin recovery to the 17%–17.5% band be gradual or faster, and when do growth headwinds recede? (Nitin Padmanabhan, Investec)
- Answer: Q1 margin decline of 120 bps was driven by salary increases, AI investments and acquisitions moving into execution. Committed to the 17%–17.5% band but no timeline given given revenue volatility. Levers include automation/AI-driven productivity, G&A optimization, bench utilization, and pyramid restructuring. Growth: Q2 guidance reflects soft demand; traction building in Americas BFSI and EMR deal ramp-ups should help. (Srini Pallia)
Healthcare Vertical Weakness
- Question: What is the outlook for the Health vertical, and when does it return to growth? (Vibhor Singhal, Nuvama)
- Answer: Decline driven by US payer/provider pressures from structural and demographic forces; budgets flattish or negative, with spend reallocated to AI and compliance (Medicare, Medicaid, ACA). New opportunities in claims, contact centers, and HIPAA-compliant clinical AI are emerging, but no specific recovery timeline was provided; current trends are baked into Q2 guidance. (Srini Pallia)
Deal Wins Decline & Pipeline Health
- Question: Large deal wins fell sharply YoY — is this just timing? (Vibhor Singhal, Nuvama)
- Answer: Yes, some decisions slipped into Q2; team directed to close early in the quarter. Pipeline is healthy: BFSI strong in Americas and Europe; tech & comms very strong in Americas; EMR strong in Europe and Americas/LATAM following recent wins; consumer modest in Americas/Europe but weak in APMEA. New opportunity areas include Sovereign AI and AI data centers. (Srini Pallia)
AI Deal Economics & Margin Impact
- Question: For large AI-driven deals, where does the margin math sit versus the current portfolio? (Vibhor Singhal, Nuvama)
- Answer: Deal-to-deal. Large operations deals will have forward productivity baked in and remain competitive; Reimagine AI services — data modernization, AI advisory, smaller AI programs — will command premium rate realization and be accretive to margins. (Aparna Iyer)
Guidance Breakdown & BFSI Insourcing
- Question: Can you split Q2 guidance into organic and inorganic, and is BFSI client insourcing fully behind? (Rajiv Berlia, JM Financial)
- Answer: No split of guidance will be provided; Mindsprint was baked in at 45 days last quarter, with about 2 months consolidated in Q1 actuals. Client insourcing in BFSI is fully behind. (Aparna Iyer)
Competition Intensity & Margin-Growth Trade-off
- Question: Has competition increased, and how do you avoid trading margin for growth? (Abhishek Bhandari, Nomura)
- Answer: AI is reshaping spend allocation — traditional IT/BPO budgets are compressing as clients push for AI and agentic disruption. Traditional cost optimization deals face pricing competition and margin pressure; net-new Reimagine AI projects carry better margins. Token costs and total cost of ownership are now central to solution design, and pricing approaches are being revisited accordingly. (Srini Pallia)
Key Takeaway
Wipro's Q1 FY27 IT services revenue of $2.61 billion grew 0.9% YoY but declined 1.2% QoQ, within guidance, while IT services margin fell 120 bps YoY to 16.0% on salary increases, large-deal ramp-ups and AI investments. Growth was led by APMEA (+13.5% YoY) and Europe (+6% YoY), offset by Americas 2 (-7.3% YoY), Health (-3.0% YoY) and EMR (-8.9% YoY). Order bookings totaled $3.4 billion, including $1.6 billion from 13 large deals, with some decisions slipping into Q2. Strategically, management is executing a consulting-led, AI-powered strategy: the Mindsprint acquisition closed and moved to execution, the AI-native business unit scaled, the Applied AI Center of Excellence for Anthropic's Claude launched, and Wipro Ventures is now focused on AI/data/security startups. Management guided Q2 FY27 at -1.5% to +0.5% QoQ CC ($2.574–$2.627 billion), citing macro uncertainty, and reaffirmed the 17%–17.5% margin band without a timeline. Key watchpoints include US Healthcare pressures, EMR softness, competitive pricing in traditional deals, and the pace of AI-led demand conversion.